MEDNAX reported Q4 2019 results with net revenue of $905 million and earnings from continuing operations of $0.40 per share. Adjusted EPS from continuing operations was $0.91. The company also announced a unilateral, multi-state termination by UnitedHealth Group.
Net revenue for the fourth quarter was $905 million.
Net income for the fourth quarter was $33 million.
Adjusted EBITDA for the fourth quarter was $132 million.
Adjusted EPS from continuing operations was $0.91.
For the first quarter of 2020, MEDNAX expects Adjusted EPS to be in the range of $0.55 to $0.63 and Adjusted EBITDA to be $95 million at the midpoint, with a range of between $90 million and $100 million.
Analyze how earnings announcements historically affect stock price performance